Nabla Bio
We use AI to design antibodies for intractable diseases
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
- Website
- nabla.bio
- City
- Boston
- Country
- United States
- YC batch
- Summer 2020
- Team
- 8 people
- Stage
- Growth stage
- AI-native
- Yes
More Health & bio in Boston
WHOOP$10.1bn
Wearable technology. Valued at $10.1bn (March 2026).
Ginkgo BioworksHiring
Our mission is to make biology easier to engineer.
Modern HealthHiring
A mental health benefits platform for employers.
TetraScience
The only R&D data cloud for life sciences
OpenBiome
A nonprofit stool bank enabling access to fecal transplants.
SiPhox HealthHiring
At-Home health monitoring with silicon photonic chips for data centers
Claim this profile
Free and instant: prove you run nabla.bio and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Nabla Bio across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Nabla Bio's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
